Two Different Initial Treatment Regimens of Ranibizumab in Myopic Choroidal Neovascularization: 12-Month Results From a Randomized Controlled Study
Clinical and Experimental Ophthalmology - United Kingdom
doi 10.1111/ceo.13424
Full Text
Open PDFAbstract
Available in full text
Date
November 22, 2018
Authors
Publisher
Wiley